Business / Finance RSS Feed - Business / Finance

Universal Biosensors agrees to modify collaboration arrangements with Siemens Healthcare Diagnostics

Universal Biosensors announced today that it has agreed amendments to its arrangements with Siemens Healthcare Diagnostics Inc. The parties have agreed to shift the focus of their joint product development activities, provide prepayment of milestones to UBI and improved strip pricing to support Siemens’ entry into the point-of-care PT-INR testing market. [More]
Merck reports record results for 2015

Merck reports record results for 2015

Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years. [More]
Quantum Plastics acquires wheelchair stabilizing device company, Transfer Solutions

Quantum Plastics acquires wheelchair stabilizing device company, Transfer Solutions

Quantum Plastics, LLC (Quantum) is expanding its product line with the acquisition of the popular wheelchair stabilizing device company, Transfer Solutions. [More]
Ethicon agrees to acquire NeuWave Medical

Ethicon agrees to acquire NeuWave Medical

Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems. [More]
New co-marketing deal to make AMRA Profiler protocol available on future GE Healthcare MRI scanners

New co-marketing deal to make AMRA Profiler protocol available on future GE Healthcare MRI scanners

AMRA has announced at the European Congress of Radiology in Vienna, Austria, that it has entered into a new co-marketing agreement with GE Healthcare, a leading provider of MRI systems. [More]
IRIDEX reports revenues of $12.1 million for fourth quarter 2015

IRIDEX reports revenues of $12.1 million for fourth quarter 2015

IRIDEX Corporation today reported financial results for the fourth quarter and year ended January 2, 2016. [More]
CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

The Centre for Addiction and Mental Health and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression. [More]
Teleradiology Specialists reports record growth in January

Teleradiology Specialists reports record growth in January

Teleradiology Specialists is positioned for explosive volume and market share growth in 2016 after completing a record number of reads in January. [More]
eviCore healthcare acquires Boston-based QPID Health

eviCore healthcare acquires Boston-based QPID Health

eviCore healthcare, a company committed to enabling better outcomes for patients, payers and providers through advanced medical benefits management, today announced that it has acquired Boston-based QPID Health. [More]
China Biologic's total sales increase by 22.6% in RMB terms to $68.3 million in Q4 2015

China Biologic's total sales increase by 22.6% in RMB terms to $68.3 million in Q4 2015

China Biologic Products, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2015. [More]
Insulet partners with Mode AGC to develop OmniPod Artificial Pancreas system

Insulet partners with Mode AGC to develop OmniPod Artificial Pancreas system

Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod Insulin Management System (OmniPod System), today announced a license agreement and partnership with Mode AGC (Automated Glucose Control LLC), to develop and incorporate the advanced artificial pancreas algorithm created by renowned researchers Francis Doyle PhD, Eyal Dassau PhD, and Howard Zisser MD. [More]
PolyPid closes $22 million private equity financing

PolyPid closes $22 million private equity financing

PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing. [More]
Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou’s intellectual property. [More]
New study shows beneficial effects of fish consumption during pregnancy

New study shows beneficial effects of fish consumption during pregnancy

A new study supports the theory that the detrimental effects of low-level exposure to mercury may be outweighed by the beneficial effects of fish consumption. [More]

WebMD Health reports record revenue, earnings for fourth quarter and full year 2015

WebMD Health Corp., the leading source of health information, today announced fourth quarter and full year financial results for 2015. [More]
Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, today announced a strategic partnership with Baylor Miraca Genetics Laboratories, a global leader in genetic testing, to provide their customers access to a broad range of targeted genomics and metabolomics services. [More]
Regulus reports net loss of $7.2 million for fourth quarter 2015

Regulus reports net loss of $7.2 million for fourth quarter 2015

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights. [More]
ResMed announces definitive agreement to acquire Brightree

ResMed announces definitive agreement to acquire Brightree

ResMed, the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced a definitive agreement to acquire privately held Brightree, a leader in business management and clinical software applications for the post-acute care industry. [More]
Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings, Inc., a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $3M investment from an institutional investor. Under the terms of the agreement, the investor will be issued $3.3M worth of Series H Convertible Preferred Stock (including 10% original issue discount) from the Company and five year warrants exercisable for 13,200,000 shares of common stock at $0.40 per share. [More]
BistroMD, Fitness Icon Denise Austin partner to create branded meal-delivery program

BistroMD, Fitness Icon Denise Austin partner to create branded meal-delivery program

BistroMD, the leader in home diet meal delivery, announced a licensing partnership today with Fitness Icon Denise Austin to create a branded meal-delivery program. The program is a natural extension of bistroMD's mission to empower people to lose weight while eating great tasting, nutritious foods, and blends with Denise's healthy lifestyle philosophy. [More]
Advertisement
Advertisement